A COVID-19 vaccine developed in Edmonton is moving forward to human trials this summer.
Entos Pharmaceuticals, led by University of Alberta researcher Dr. John Lewis, has selected two promising vaccine prototypes to start testing in people.
"We have two really excellent candidates that produce a very strong neutralizing antibody immune response [in animals]," Lewis told Global News.
The Government of Canada has granted Lewis $4.2 million to take the project to the next step, part of the Canadian Institutes of Health Research rapid research funding competition, which awarded $109 million to 139 research teams across the country this month.
Made-in-Alberta COVID-19 vaccine prototypes to be tested on humans by Alex Antoneshyn, CTV News Edmonton